ACUTAAS Acutaas Chemicals Q4 FY25 results (Jan–Mar 2025) and concall
Acutaas Chemical (formerly Ami Organics Limited) reported a landmark FY25, crossing INR1,000 crore in revenue with a 40.3% YoY growth. Q4 FY25 saw robust performance with revenue up 37.1% YoY and EBITDA margin expanding significantly to 27.5%. The company announced its rebranding to Acutaas Chemicals Limited, reflecting its diversified specialty chemicals vision. While facing global economic uncertainties and subdued demand in some segments, management remains optimistic about continued growth, driven by CDMO business, new electrolyte additive production, and recovery in the semiconductor segm
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 |
|---|---|---|
| Revenue | 271 | 304 |
| EBITDA | 67 | 84 |
| Net profit | 45 | 63 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
